✦ LIBER ✦

P092 Serum level of ELAM-1 in patients suffering from psoriasis

✍ Scribed by D. Krasowska; A. Pietrzak; G. Chodorowska; B. Lecewicz-Toruń

Book ID: 118604531
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 116 KB
Volume: 9
Category: Article
ISSN: 0926-9959
DOI: 10.1016/s0926-9959(97)89566-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated serum-soluble ELAM-1 levels in

Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis

✍ L. Kowalzick; K. Neuber; M. Weichenthal; I. Köhler; J. Ring 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 320 KB

Serum lipoperoxide level in patients suf

Serum lipoperoxide level in patients suffering from liver diseases

✍ T. Suematsu; T. Kamada; H. Abe; S. Kikuchi; K. Yagi 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Serum levels of proinflammatory cytokine

Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia

✍ Abdullah Abanmi; Fahad Al Harthi; Rokaiyah Al Agla; Haseeb Ahmad Khan; Mohammad 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Plasma concentration of selected neurope

Plasma concentration of selected neuropeptides in patients suffering from psoriasis

✍ Adam Reich; Alina Orda; Beata Wiśnicka; Jacek C. Szepietowski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Evaluation of serum mucoproteins in pati

Evaluation of serum mucoproteins in patients suffering from liver cancers

✍ T. Mukhopadhyay; A. Giri; A. Dasgupta 📂 Article 📅 2003 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 274 KB

Serum levels of interleukin-18 and s-ICA

Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations

✍ S Gangemi; RA Merendino; F Guarneri; PL Minciullo; G DiLorenzo; M Pacor; SP Cann 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

## ABSTRACT **Objective** To find new aspects of the systemic involvement of the Immune System in psoriasis, we determined serum levels of interleukin‐18 (IL‐18) (Th1‐inducing factor cytokine), CD30 (Th2 marker) and sICAM‐1 (adhesion molecule). In addition we evaluated the correlation between these